Middle East & Africa Retinal Disorder Treatment Market Size & Outlook
Related Markets
MEA retinal disorder treatment market highlights
- The MEA retinal disorder treatment market generated a revenue of USD 940.9 million in 2023.
- The market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, macular degeneration was the largest revenue generating type in 2023.
- Diabetic Retinopathy is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 940.9 million |
| Market revenue in 2030 | USD 1,873.0 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Macular degeneration |
| Fastest growing segment | Diabetic Retinopathy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetic Retinopathy, Other Types, Macular Degeneration |
| Key market players worldwide | Santen Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, GrayBug, Takeda Pharmaceutical Co Ltd, Bayer AG, AbbVie Inc, Roche Holding AG ADR, Acucela, Pfizer Inc, Kubota Pharmaceutical Holdings |
Other key industry trends
- In terms of revenue, MEA region accounted for 6.9% of the global retinal disorder treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,739.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Retinal Disorder Treatment Market Scope
Retinal Disorder Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Kubota Pharmaceutical Holdings | View profile | 1-10 | Tokyo, Tokyo, Japan, Asia | https://www.kubotaholdings.co.jp/ |
| Acucela | View profile | 51-100 | Seattle, Washington, United States, North America | http://acucela.com |
| GrayBug | View profile | 1-10 | Redwood City, California, United States, North America | https://www.graybug.vision |
| Santen Pharmaceutical Co Ltd | View profile | 1807 | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, Japan, 530-8552 | http://www.santen.co.jp |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Regeneron Pharmaceuticals Inc | View profile | 13450 | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 | https://www.regeneron.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Middle East & Africa retinal disorder treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to retinal disorder treatment market will help companies and investors design strategic landscapes.
Macular degeneration was the largest segment with a revenue share of 43.85% in 2023. Horizon Databook has segmented the Middle East & Africa retinal disorder treatment market based on diabetic retinopathy, other types, macular degeneration covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa retinal disorder treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa retinal disorder treatment market databook
-
Our clientele includes a mix of retinal disorder treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa retinal disorder treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa retinal disorder treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA retinal disorder treatment market size, by country, 2018-2030 (US$M)
Middle East & Africa Retinal Disorder Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
